Obesity Surgery

, 19:1542

Cost-effectiveness and Budget Impact of Obesity Surgery in Patients with Type 2 Diabetes in Three European Countries(II)

  • Marco Anselmino
  • Tanja Bammer
  • José Maria Fernández Cebrián
  • Frederic Daoud
  • Giuliano Romagnoli
  • Antonio Torres
Other

DOI: 10.1007/s11695-009-9946-z

Cite this article as:
Anselmino, M., Bammer, T., Fernández Cebrián, J.M. et al. OBES SURG (2009) 19: 1542. doi:10.1007/s11695-009-9946-z

Abstract

Background

This study aimed to establish a payer-perspective cost-effectiveness and budget impact model of adjustable gastric banding (AGB) and gastric bypass (GBP) vs. conventional treatment (CT) in patients with a body mass index (BMI) ≥ 35 kg.m−2 and type 2 diabetes mellitus (T2DM) in Austria, Italy, and Spain.

Methods

A health economics model described in a previous publication was applied to resource utilization and cost data in AGB, GBP, and CT from Austria, Italy, and Spain in 2009.

Results

The base case time scope is 5 years; the annual discount rate for utilities and costs is 3.5%. In Austria and Italy, both AGB and GBP are cost-saving and are thus dominant in terms of incremental cost-effectiveness ratio compared to CT. In Spain, AGB and GBP yield a moderate cost increase but are cost-effective, assuming a willingness-to-pay threshold of 30,000 euro per quality adjusted life-year. Under worst-case analysis, AGB and GBP remain cost-saving or around breakeven in Austria and Italy and remain cost-effective in Spain.

Conclusion

In patients with T2DM and BMI ≥ 35 kg.m−2 at 5-year follow-up vs. CT, AGB and GBP are not only clinically effective and safe but represent satisfactory value for money from a payer perspective in Austria, Italy, and Spain.

Keywords

Obesity surgery Gastric bypass Adjustable gastric banding Cost-effectiveness Budget impact EQ-5D utility Diabetes 

Abbreviations

ABG

Adjustable gastric banding

BI

Budget impact

CT

Conventional treatment

DRG

Diagnostic-related group

EQ-5D

EuroQol three-level five-dimensional

GBP

Gastric bypass

HTA

Health technology assessment

LKF

Leistungsorientierte Krankenanstaltenfinanzierung: the point-based Austrian service-based hospital funding

ICER

Incremental cost-effectiveness ratio

QALYs

Quality adjusted life-years

T2DM

Type 2 diabetes mellitus

WTP

Willingness to pay: the maximum ICER accepted by health care payers

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Marco Anselmino
    • 1
  • Tanja Bammer
    • 2
  • José Maria Fernández Cebrián
    • 3
  • Frederic Daoud
    • 4
  • Giuliano Romagnoli
    • 5
  • Antonio Torres
    • 6
  1. 1.Bariatric Surgery UnitAzienda Ospedaliera PisanaPisaItaly
  2. 2.Surgery Unit BKH KufsteinKufsteinAustria
  3. 3.Fundación Hospital AlcorcónAlcorcónSpain
  4. 4.Medextens Clinical Epidemiology Dept.ParisFrance
  5. 5.U.O. di Chirurgia Ospedale Civile di Legnano, P.O, di MagentaMagentaItaly
  6. 6.Complutense University of Madrid Hospital Clinico San CarlosMadridSpain

Personalised recommendations